Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Director comp.
Director departure

eFFECTOR Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 4 WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Exercised 33,799 options to buy @ $0.52, valued at $17.6k
05/16/2023 4 WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 6,401 shares @ $0.459, valued at $2.9k
05/16/2023 4 Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 4,863 shares @ $0.459, valued at $2.2k
01/24/2023 4 Gallagher Brian M. Jr. (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 50,938 options to buy @ $0.4688, valued at $23.9k
01/24/2023 4 Smither John W (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 36,875 options to buy @ $0.4688, valued at $17.3k
01/24/2023 4 Harrington-Smith Kristen (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 28,125 options to buy @ $0.4688, valued at $13.2k
01/24/2023 4 Klencke Barbara (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 28,125 options to buy @ $0.4688, valued at $13.2k
01/24/2023 4 Ehrlich Christopher B (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 35,938 options to buy @ $0.4688, valued at $16.8k
01/24/2023 4 Bhatt Elizabeth (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $0.4688, valued at $14.1k
01/19/2023 4 WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 1,000,000 options to buy @ $0.47, valued at $470k
01/19/2023 4 Warner Douglas J (Chief Medical Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 250,000 options to buy @ $0.47, valued at $117.5k
01/19/2023 4 Gandhi Mayank (Chief Business Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $0.47, valued at $70.5k
01/19/2023 4 Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 500,000 options to buy @ $0.47, valued at $235k
11/16/2022 4 Byrnes Michael (CFO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 4,651 shares @ $0.4684, valued at $2.2k
11/16/2022 4 WORLAND STEPHEN T (CEO) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 6,047 shares @ $0.4684, valued at $2.8k
10/06/2022 4 Ehrlich Christopher B (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Bought 346 shares @ $0.57, valued at $197.2
09/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
09/27/2022 4 Ehrlich Christopher B (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Bought 18,867 shares @ $0.55, valued at $10.4k
08/11/2022 3 Carlyle Group Inc. (10% Owner) has filed a Form 3 on eFFECTOR Therapeutics, Inc.
08/08/2022 4 Warner Douglas J (Chief Medical Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 618,160 options to buy @ $0.8975, valued at $554.8k
08/08/2022 3 Warner Douglas J (Chief Medical Officer) has filed a Form 3 on eFFECTOR Therapeutics, Inc.
08/03/2022 4 Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Sold 25,896 shares @ $0.786, valued at $20.4k
Sold 807 shares @ $0.786, valued at $634.3
Sold 27,348 shares @ $0.797, valued at $21.8k
Sold 853 shares @ $0.797, valued at $679.8
Sold 57,580 shares @ $0.804, valued at $46.3k
Sold 1,796 shares @ $0.804, valued at $1.4k
07/29/2022 4 Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Sold 31,533 shares @ $0.892, valued at $28.1k
Sold 984 shares @ $0.892, valued at $877.7
07/27/2022 4 Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Sold 2,210 shares @ $0.931, valued at $2.1k
Sold 69 shares @ $0.931, valued at $64.2
Sold 2,691 shares @ $0.904, valued at $2.4k
Sold 84 shares @ $0.904, valued at $75.9
Sold 42,344 shares @ $0.892, valued at $37.8k
Sold 1,321 shares @ $0.892, valued at $1.2k
07/22/2022 4 Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Sold 9,726 shares @ $1.001, valued at $9.7k
Sold 304 shares @ $1.001, valued at $304.3
Sold 2,584 shares @ $0.955, valued at $2.5k
Sold 81 shares @ $0.956, valued at $77.4
Sold 7,383 shares @ $0.91, valued at $6.7k
Sold 231 shares @ $0.911, valued at $210.4
07/19/2022 4 Presidio Management Group X LLC (10% Owner) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Sold 44,477 shares @ $1.108, valued at $49.3k
Sold 1,423 shares @ $1.108, valued at $1.6k
Sold 20,352 shares @ $1.08, valued at $22k
Sold 635 shares @ $1.081, valued at $686.4
Sold 2,670 shares @ $1, valued at $2.7k
Sold 84 shares @ $1, valued at $84
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 McNulty Alana B. (Chief Business Officer) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 150,000 options to buy @ $1.49, valued at $223.5k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 Harrington-Smith Kristen (Director) has filed a Form 4 on eFFECTOR Therapeutics, Inc.
Txns: Granted 13,333 options to buy @ $1.65, valued at $22k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy